Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats

Neuropsychopharmacology

Volumn 39, Issue 10, 2014, Pages 2309-2316

  Thorn, David A ^a   Jing, Li ^a,b   Qiu, Yanyan ^a   Gancarz Kausch, Amy M ^a   Galuska, Chad M ^c   Dietz, David M ^a   Zhang, Yanan ^d   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c School of Business   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PARTIAL AGONIST; RECEPTOR; RO 5263397; TRACE AMINE ASSOCIATED RECEPTOR 1; TRACE AMINE ASSOCIATED RECEPTOR 1 AGONIST; UNCLASSIFIED DRUG; DOPAMINE UPTAKE INHIBITOR; G PROTEIN COUPLED RECEPTOR; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG SEEKING BEHAVIOR; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; AGONISTS; ANIMAL; COCAINE-RELATED DISORDERS; DEPTH PERCEPTION; DRUG EFFECTS; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CUES; DOPAMINE UPTAKE INHIBITORS; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; MALE; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SELF ADMINISTRATION; SPACE PERCEPTION;

EID: 84906322927     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.91     Document Type: Article

References (38)

1. Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM (2012). Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-Associated receptor 1. Pharmacol Biochem Behav 101: 201-207
2. An XF, Zhang Y, Winter JC, Li JX (2012). Effects of imidazoline I(2) receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 101: 354-359
3. Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR et al (2013). Modification of cocaine self-Administration by buspirone (buspar(R)): Potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol 16: 445-458
4. Boctor SY, Martinez JL Jr., Koek W, France CP (2007). The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding. Eur J Pharmacol 571: 39-43
5. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al (2001). Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98: 8966-8971
6. Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013). The reinstatement model of drug relapse: Recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229: 453-476
7. Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG et al (2009). The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106: 20081-20086
8. Bradberry CW (2000). Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 20: 7109-7115
9. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al (2001). Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60: 1181-1188
10. Epstein DH, Preston KL, Stewart J, Shaham Y (2006). Toward a model of drug relapse: An assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189: 1-16
11. Galuska CM, Banna KM, Willse LV, Yahyavi-Firouz-Abadi N, See RE (2011). A comparison of economic demand and conditionedcued reinstatement of methamphetamine-seeking or foodseeking in rats. Behav Pharmacol 22: 312-323
12. Gancarz AM, Kausch MA, Lloyd DR, Richards JB (2012). Betweensession progressive ratio performance in rats responding for cocaine and water reinforcers. Psychopharmacology (Berl) 222: 215-223
13. Grandy DK (2007). Trace amine-Associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116: 355-390
14. Hursh SR, Silberberg A (2008). Economic demand and essential value. Psychol Rev 115: 186-198
15. Kalivas PW, Lalumiere RT, Knackstedt L, Shen H (2009). Glutamate transmission in addiction. Neuropharmacology 56(Suppl 1): 169-173
16. Kalivas PW, Volkow ND (2011). New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 16: 974-986
17. Kampman KM, Dackis C, Pettinati HM, Lynch KG, Sparkman T, O'Brien CP (2011). A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence. Addict Behav 36: 217-221
18. Kimmel HL, Nye JA, Voll R, Mun J, Stehouwer J, Goodman MM et al (2012). Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys. Synapse 66: 501-508
19. Li JX, Shah AP, Patel SK, Rice KC, France CP (2013). Modification of the behavioral effects of morphine in rats by serotonin 5-HT(1)A and 5-HT(2)A receptor agonists: Antinociception, drug discrimination, and locomotor activity. Psychopharmacology (Berl) 225: 791-801
20. Li Y, Acerbo MJ, Robinson TE (2004). The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 20: 1647-1654
21. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H et al (2008). Trace amine-Associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324: 948-956
22. Miller GM (2011). The emerging role of trace amine-Associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem 116: 164-176
23. Napier TC, Herrold AA, de Wit H (2013). Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev 37(9 Pt A): 2081-2086
24. Oleson EB, Richardson JM, Roberts DC (2011). A novel IV cocaine self-Administration procedure in rats: Differential effects of dopamine, serotonin, and GABA drug pre-Treatments on cocaine consumption and maximal price paid. Psychopharmacology (Berl) 214: 567-577
25. Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF et al (2013). Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem 56: 6901-6916
26. Pierce RC, O'Brien CP, Kenny PJ, Vanderschuren LJ (2012). Rational development of addiction pharmacotherapies: Successes, failures, and prospects. Cold Spring Harb Perspect Med 2: A012880
27. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R et al (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108: 8485-8490
28. Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velazquez-Sanchez C, Sotnikova TD et al (2012). Trace amine-Associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72: 934-942
29. Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D et al (2013). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-And antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18: 543-556
30. Steketee JD, Kalivas PW (2011). Drug wanting: Behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63: 348-365
31. Thorn DA, Winter JC, Li JX (2012). Agmatine attenuates methamphetamine-induced conditioned place preference in rats. Eur J Pharmacol 680: 69-72
32. Thorn DA, Zhang C, Zhang Y, Li JX (2014). The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats. Neurosci Lett 566: 67-71
33. Tzschentke TM (1998). Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56: 613-672
34. Uys JD, Knackstedt L, Hurt P, Tew KD, Manevich Y, Hutchens S et al (2011). Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity. Neuropsychopharmacology 36: 2551-2560
35. Vocci FJ, Elkashef A (2005). Pharmacotherapy and other treatments for cocaine abuse and dependence. Curr Opin Psychiatry 18: 265-270
36. Wolf ME, Ferrario CR (2010). AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine. Neurosci Biobehav Rev 35: 185-211
37. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P et al (2007). The Trace Amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia. Genes Brain Behav 6: 628-639
38. Xie Z, Miller GM (2009). Trace amine-Associated receptor 1 as a monoaminergic modulator in brain. Biochem Pharmacol 78: 1095-1104